EKFZ Else Kroener Fresenius Center for Optogenetic Therapies, University Medical Center Goettingen
Göttingen, 37075, Germany
NCT Number: NCT07056738
The aim of this study is an explorative prospective observation of retinal ganglion cell degeneration and/or inner retina degeneration in Retinitis pigmentosa patients. The rate and patterns of progression will be correlated to the outer retina layers as well as clinical and genetic data of patients. Secondary goal is to determine potential parameters for optogenetic treatment eligibility.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Göttingen, 37075, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
OCT, OCTA, RNFL-OCT, fundus autofluorescence, fundus imaging, flaremeter, fundus and slit lamp examination
Time frame: 6 months intervals, overall time span 5 years
Measuring the thickness of the ganglion cell inner plexiforme layer (GCIPL) in macula optical coherence tomography (OCT) imaging of the retina.
Time frame: 6 months intervals, overall time span 5 years
Measuring the thickness of the retinal nerve fiber layer (RNFL) in macular and optic nerve optical coherence tomography (OCT) imaging of the retina.
Time frame: 6 months intervals, overall time span 5 years
Perfusion density (PD), vessel density (VD), intercapillary area size (ICA) of superficial retinal plexus (SRP) and deep retinal plexus (DRP) in OCTA imaging (optical coherence tomography angiography)
Time frame: 6-12 months intervals, overall time span 5 years
Thickness and morphology of inner and outer retinal layers measured with optical coherence tomography (OCT), fundus photography, fundus autofluorescence (FAF)
Time frame: 6 months intervals, overall time span 5 years
Changes in functional parameters such as best corrected visual acuity
Time frame: 6 months intervals, overall time span 5 years
Find correlations of imaging outcomes with the clinical data of patients, such as sex, age, age of onset of disease
Time frame: 6 months intervals, overall time span 5 years
Find correlations of imaging outcomes with the Retinitis pigmentosa mutation and inheritance pattern of patients
Time frame: 6 months intervals, overall time span 5 years
Correlation of imaging outcomes and disease progression with inflammatory markers collected with serum blood samples and flaremeter as well as slit lamp and fundus examination findings
Time frame: 6 months intervals, overall time span 5 years
Correlation of changes in inner retina and outer retina of collected imaging data over time.
University Medical Center Goettingen
Other
Longitudinal Characterization of Inner Retina Health in Low Vision Retinitis Pigmentosa Patients to Optimize Retinal Ganglion Cell-based Optogenetic Vision Restoration Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07509229
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Tel Litwinsky, Israel
View Trial DetailsNCT05921162
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Cuttack, Odisha, India
View Trial DetailsNCT05158049
Choroid Diseases, Choroideremia
Melbourne E., Victoria, Australia
View Trial DetailsNCT06912633
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Phoenix, Arizona, United States
View Trial Details